Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response

Myelodysplastic syndromes (MDS) consist of a group of hematological malignancies characterized by ineffective hematopoiesis, cytogenetic abnormalities, and often a high risk of transformation to acute myeloid leukemia (AML). So far, there have been only a very limited number of studies assessing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Siamoglou, Stavroula, Boers, Ruben, Koromina, Maria, Boers, Joachim, Tsironi, Anna, Chatzilygeroudi, Theodora, Lazaris, Vasileios, Verigou, Evgenia, Kourakli, Alexandra, van IJcken, Wilfred F. J., Gribnau, Joost, Symeonidis, Argiris, Patrinos, George P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127336/
https://www.ncbi.nlm.nih.gov/pubmed/37098643
http://dx.doi.org/10.1186/s40246-023-00483-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127336/
https://www.ncbi.nlm.nih.gov/pubmed/37098643
http://dx.doi.org/10.1186/s40246-023-00483-7

Ejemplares similares